Crinetics Pharmaceuticals (CRNX) News Today → Tech GIANT’s Plans to Revolutionize Crypto… (From Crypto 101 Media) (Ad) Free CRNX Stock Alerts $48.00 -1.42 (-2.87%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineInvestors in Crinetics Pharmaceuticals (NASDAQ:CRNX) have seen solid returns of 196% over the past three yearsfinance.yahoo.com - May 11 at 12:45 PMRichard Scott Struthers Sells 107,448 Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Stockinsidertrades.com - May 11 at 9:21 AMCrinetics Pharmaceuticals, Inc.: Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)finanznachrichten.de - May 11 at 7:45 AMCrinetics Pharmaceuticals (NASDAQ:CRNX) Announces Quarterly Earnings Results, Misses Expectations By $0.09 EPSmarketbeat.com - May 10 at 10:41 PMBuy Rating for Crinetics Pharmaceuticals: Strong Financials and Promising Clinical Datamarkets.businessinsider.com - May 10 at 9:37 PMInsider Selling: Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) CEO Sells 107,448 Shares of Stockmarketbeat.com - May 10 at 6:44 PMCrinetics Pharmaceuticals' (CRNX) Buy Rating Reaffirmed at HC Wainwrightmarketbeat.com - May 10 at 6:18 PMCrinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - May 10 at 5:38 PMCrinetics Pharmaceuticals Inc (CRNX) Reports Q1 2024 Financial Resultsfinance.yahoo.com - May 10 at 4:36 PMBuy Rating Affirmed for Crinetics Pharmaceuticals on Strong Drug Pipeline and Market Potentialmarkets.businessinsider.com - May 10 at 10:56 AMCrinetics Pharmaceuticals, Inc.: Crinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Updatefinanznachrichten.de - May 10 at 5:55 AMCRNX Stock Earnings: Crinetics Pharmaceuticals Misses EPS, Beats Revenue for Q1 2024investorplace.com - May 9 at 10:07 PMCrinetics Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Updateglobenewswire.com - May 9 at 4:05 PMCrinetics Pharmaceuticals (NASDAQ:CRNX) Reaches New 52-Week High on Analyst Upgradeamericanbankingnews.com - May 9 at 2:22 AMPromising Outlook for Crinetics Pharmaceuticals Ahead of CRN04894 Phase 2 Data Releasemarkets.businessinsider.com - May 8 at 5:56 PMCrinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs at ENDO 2024finance.yahoo.com - May 8 at 5:56 PMCrinetics Pharmaceuticals (CRNX) to Release Quarterly Earnings on Thursdayamericanbankingnews.com - May 8 at 6:40 AMCrinetics Pharmaceuticals (NASDAQ:CRNX) Price Target Increased to $97.00 by Analysts at Piper Sandleramericanbankingnews.com - May 8 at 5:52 AMCrinetics Pharmaceuticals (NASDAQ:CRNX) Price Target Raised to $97.00marketbeat.com - May 7 at 8:32 AMCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Holdings Boosted by Lisanti Capital Growth LLCmarketbeat.com - May 6 at 10:39 PMCrinetics Pharmaceuticals (CRNX) Set to Announce Earnings on Thursdaymarketbeat.com - May 3 at 10:33 AMCrinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024globenewswire.com - May 2 at 4:05 PMShort Interest in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Grows By 6.3%americanbankingnews.com - May 2 at 4:46 AM101,196 Shares in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Bought by abrdn plcmarketbeat.com - April 29 at 5:16 AMJennison Associates LLC Boosts Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)marketbeat.com - April 23 at 8:30 AMInsider Selling: Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Insider Sells 14,375 Shares of Stockinsidertrades.com - April 18 at 6:17 AMCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Insider Sells $639,256.25 in Stockmarketbeat.com - April 17 at 6:38 PMCrinetics Pharmaceuticals, Inc.: Crinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)finanznachrichten.de - April 12 at 8:19 AMCrinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)finance.yahoo.com - April 11 at 8:29 PMCrinetics Pharmaceuticals Announces April 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)globenewswire.com - April 11 at 4:05 PMCrinetics Pharmaceuticals (NASDAQ:CRNX) Stock Price Up 5.1%marketbeat.com - April 11 at 4:01 PMCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) CEO Sells $2,013,560.67 in Stockinsidertrades.com - April 9 at 4:20 AMVanguard Group Inc. Increases Stake in Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX)marketbeat.com - April 5 at 4:07 AMCrinetics Pharmaceuticals (NASDAQ:CRNX) Sees Large Volume Increasemarketbeat.com - April 3 at 4:50 PMCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Director Stephanie Okey Sells 17,500 Sharesinsidertrades.com - April 3 at 4:58 AMCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Recommendation of "Moderate Buy" from Analystsmarketbeat.com - April 3 at 2:20 AMCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Sees Significant Growth in Short Interestmarketbeat.com - April 2 at 7:18 PMCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Director Sells $811,650.00 in Stockmarketbeat.com - April 2 at 6:38 PMCrinetics Pharmaceuticals (NASDAQ:CRNX) Hits New 1-Year High at $48.00marketbeat.com - April 1 at 9:26 AMCrinetics Pharmaceuticals COO sells shares worth over $1.4 millioninvesting.com - March 28 at 6:13 PMInsiders Are Dumping These 5 Healthcare Stocksinsidermonkey.com - March 28 at 1:12 PMCrinetics Pharmaceuticals' (CRNX) "Market Outperform" Rating Reaffirmed at JMP Securitiesmarketbeat.com - March 28 at 11:29 AMInsider Sell: COO Jeff Knight Sells 32,359 Shares of Crinetics Pharmaceuticals Inc (CRNX)finance.yahoo.com - March 27 at 10:54 AMInsider Selling: Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) COO Sells 32,359 Shares of Stockinsidertrades.com - March 27 at 4:57 AMCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) COO Jeff E. Knight Sells 32,359 Sharesmarketbeat.com - March 26 at 6:41 PMCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Insider Dana Pizzuti Sells 15,089 Sharesinsidertrades.com - March 23 at 8:48 AMCrinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Insider Sells $664,821.34 in Stockmarketbeat.com - March 22 at 8:10 PMDirector Matthew Fust Sells 60,000 Shares of Crinetics Pharmaceuticals Inc (CRNX)finance.yahoo.com - March 22 at 7:30 PMInsider Sell: Chief Medical and Development Officer Dana Pizzuti Sells 15,089 Shares of ...finance.yahoo.com - March 22 at 7:30 PMEquities Analysts Set Expectations for Crinetics Pharmaceuticals, Inc.'s FY2025 Earnings (NASDAQ:CRNX)marketbeat.com - March 22 at 8:38 AM Get Crinetics Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRNX and its competitors with MarketBeat's FREE daily newsletter. Email Address The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. CRNX Media Mentions By Week CRNX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRNX News Sentiment▼0.170.56▲Average Medical News Sentiment CRNX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRNX Articles This Week▼275▲CRNX Articles Average Week Get Crinetics Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Summit Therapeutics News Today Biohaven News Today Axsome Therapeutics News Today Insmed News Today Ultragenyx Pharmaceutical News Today Prestige Consumer Healthcare News Today Alkermes News Today Perrigo News Today HUTCHMED News Today Xenon Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRNX) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithCollapse of the Petrodollar Colonial MetalsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Crinetics Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
